IL6 and neoplasm: Thus, SPRY2 deficiency‐driven p38‐IL6 signalling axis may support resistance to ADT by promoting self‐sufficiency for androgens within the tumour, at least in part, through increased levels of intra‐tumoral cholesterol required for androgen biosynthesis (Fig 7D).